224 related articles for article (PubMed ID: 28228402)
1. Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus.
Lin Y; Zhang T; Feng P; Qiu M; Liu Q; Li S; Zheng P; Kong Y; Levi M; Li C; Wang W
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F914-F925. PubMed ID: 28228402
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen attenuates development of lithium-induced nephrogenic diabetes insipidus in rats.
Tingskov SJ; Hu S; Frøkiær J; Kwon TH; Wang W; Nørregaard R
Am J Physiol Renal Physiol; 2018 May; 314(5):F1020-F1025. PubMed ID: 29357422
[TBL] [Abstract][Full Text] [Related]
3. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
Zhang Y; Peti-Peterdi J; Müller CE; Carlson NG; Baqi Y; Strasburg DL; Heiney KM; Villanueva K; Kohan DE; Kishore BK
J Am Soc Nephrol; 2015 Dec; 26(12):2978-87. PubMed ID: 25855780
[TBL] [Abstract][Full Text] [Related]
4. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
Bedford JJ; Weggery S; Ellis G; McDonald FJ; Joyce PR; Leader JP; Walker RJ
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1324-31. PubMed ID: 18596116
[TBL] [Abstract][Full Text] [Related]
5. 4-PBA improves lithium-induced nephrogenic diabetes insipidus by attenuating ER stress.
Zheng P; Lin Y; Wang F; Luo R; Zhang T; Hu S; Feng P; Liang X; Li C; Wang W
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F763-F776. PubMed ID: 27385737
[TBL] [Abstract][Full Text] [Related]
6. Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla.
Rieg T; Tang T; Murray F; Schroth J; Insel PA; Fenton RA; Hammond HK; Vallon V
J Am Soc Nephrol; 2010 Dec; 21(12):2059-68. PubMed ID: 20864687
[TBL] [Abstract][Full Text] [Related]
7. Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis.
Li S; Qiu M; Kong Y; Zhao X; Choi HJ; Reich M; Bunkelman BH; Liu Q; Hu S; Han M; Xie H; Rosenberg AZ; Keitel V; Kwon TH; Levi M; Li C; Wang W
J Am Soc Nephrol; 2018 Nov; 29(11):2658-2670. PubMed ID: 30305310
[TBL] [Abstract][Full Text] [Related]
8. Fluconazole Increases Osmotic Water Transport in Renal Collecting Duct through Effects on Aquaporin-2 Trafficking.
Vukićević T; Hinze C; Baltzer S; Himmerkus N; Quintanova C; Zühlke K; Compton F; Ahlborn R; Dema A; Eichhorst J; Wiesner B; Bleich M; Schmidt-Ott KM; Klussmann E
J Am Soc Nephrol; 2019 May; 30(5):795-810. PubMed ID: 30988011
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic drugs upregulate aquaporin-2 via vasopressin-2 receptor/cAMP/protein kinase A signaling in inner medullary collecting duct cells.
Kim S; Jo CH; Kim GH
Am J Physiol Renal Physiol; 2021 May; 320(5):F963-F971. PubMed ID: 33843270
[TBL] [Abstract][Full Text] [Related]
10. Aliskiren restores renal AQP2 expression during unilateral ureteral obstruction by inhibiting the inflammasome.
Wang W; Luo R; Lin Y; Wang F; Zheng P; Levi M; Yang T; Li C
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F910-22. PubMed ID: 25694485
[TBL] [Abstract][Full Text] [Related]
11. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
Li Y; Shaw S; Kamsteeg EJ; Vandewalle A; Deen PM
J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
[TBL] [Abstract][Full Text] [Related]
12. Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus.
Poulsen SB; Kristensen TB; Brooks HL; Kohan DE; Rieg T; Fenton RA
JCI Insight; 2017 Apr; 2(7):e91042. PubMed ID: 28405619
[TBL] [Abstract][Full Text] [Related]
13. Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts.
Gao M; Cao R; Du S; Jia X; Zheng S; Huang S; Han Q; Liu J; Zhang X; Miao Y; Kang J; Gustafsson JÅ; Guan Y
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8397-402. PubMed ID: 26100911
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptor β increases aquaporin 2 protein level via a posttranscriptional mechanism in renal collecting ducts.
Su W; Huang SZ; Gao M; Kong XM; Gustafsson JÅ; Xu SJ; Wang B; Zheng F; Chen LH; Wang NP; Guan YF; Zhang XY
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F619-F628. PubMed ID: 28052875
[TBL] [Abstract][Full Text] [Related]
15. Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice.
Procino G; Milano S; Carmosino M; Barbieri C; Nicoletti MC; Li JH; Wess J; Svelto M
Kidney Int; 2014 Jul; 86(1):127-38. PubMed ID: 24522493
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of angiotensin II stimulation on aquaporin-2 expression and trafficking.
Li C; Wang W; Rivard CJ; Lanaspa MA; Summer S; Schrier RW
Am J Physiol Renal Physiol; 2011 May; 300(5):F1255-61. PubMed ID: 21325494
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal regulation of aquaporin-2 abundance and degradation by protein kinase A and p38-MAP kinase.
Nedvetsky PI; Tabor V; Tamma G; Beulshausen S; Skroblin P; Kirschner A; Mutig K; Boltzen M; Petrucci O; Vossenkämper A; Wiesner B; Bachmann S; Rosenthal W; Klussmann E
J Am Soc Nephrol; 2010 Oct; 21(10):1645-56. PubMed ID: 20724536
[TBL] [Abstract][Full Text] [Related]
18. The soluble (Pro) renin receptor does not influence lithium-induced diabetes insipidus but does provoke beiging of white adipose tissue in mice.
Yang KT; Wang F; Lu X; Peng K; Yang T; David Symons J
Physiol Rep; 2017 Nov; 5(21):. PubMed ID: 29138356
[TBL] [Abstract][Full Text] [Related]
19. Genetic deletion of the P2Y2 receptor offers significant resistance to development of lithium-induced polyuria accompanied by alterations in PGE2 signaling.
Zhang Y; Pop IL; Carlson NG; Kishore BK
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F70-7. PubMed ID: 21975874
[TBL] [Abstract][Full Text] [Related]
20. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
Boone M; Kortenoeven M; Robben JH; Deen PM
Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
